Charles River Laboratories Cash on Hand 2010-2024 | CRL

Charles River Laboratories cash on hand from 2010 to 2024. Cash on hand can be defined as cash deposits at financial institutions that can immediately be withdrawn at any time, and investments maturing in one year or less that are highly liquid and therefore regarded as cash equivalents and reported with or near cash line items.
  • Charles River Laboratories cash on hand for the quarter ending June 30, 2024 was $0.179B, a 10.59% decline year-over-year.
  • Charles River Laboratories cash on hand for 2023 was $0.277B, a 18.32% increase from 2022.
  • Charles River Laboratories cash on hand for 2022 was $0.234B, a 3.03% decline from 2021.
  • Charles River Laboratories cash on hand for 2021 was $0.241B, a 5.6% increase from 2020.
Charles River Laboratories Annual Cash on Hand
(Millions of US $)
2023 $277
2022 $234
2021 $241
2020 $228
2019 $238
2018 $195
2017 $164
2016 $118
2015 $118
2014 $160
2013 $156
2012 $110
2011 $69
2010 $179
2009 $183
Charles River Laboratories Quarterly Cash on Hand
(Millions of US $)
2024-06-30 $179
2024-03-31 $327
2023-12-31 $277
2023-09-30 $157
2023-06-30 $200
2023-03-31 $202
2022-12-31 $234
2022-09-30 $194
2022-06-30 $200
2022-03-31 $242
2021-12-31 $241
2021-09-30 $213
2021-06-30 $223
2021-03-31 $465
2020-12-31 $228
2020-09-30 $243
2020-06-30 $402
2020-03-31 $372
2019-12-31 $238
2019-09-30 $165
2019-06-30 $201
2019-03-31 $126
2018-12-31 $195
2018-09-30 $139
2018-06-30 $192
2018-03-31 $188
2017-12-31 $164
2017-09-30 $124
2017-06-30 $116
2017-03-31 $132
2016-12-31 $118
2016-09-30 $106
2016-06-30 $155
2016-03-31 $157
2015-12-31 $118
2015-09-30 $74
2015-06-30 $151
2015-03-31 $152
2014-12-31 $160
2014-09-30 $131
2014-06-30 $117
2014-03-31 $170
2013-12-31 $156
2013-09-30 $130
2013-06-30 $114
2013-03-31 $100
2012-12-31 $110
2012-09-30 $83
2012-06-30 $76
2012-03-31 $61
2011-12-31 $69
2011-09-30 $81
2011-06-30 $146
2011-03-31 $159
2010-12-31 $179
2010-09-30 $137
2010-06-30 $219
2010-03-31 $222
2009-12-31 $183
2009-09-30 $192
2009-06-30 $155
2009-03-31 $170
Sector Industry Market Cap Revenue
Medical Medical Services $9.742B $4.129B
Charles River Laboratories International, Inc. is a full service, early-stage contract research organization. The company provides essential products and services to help pharmaceutical and biotechnology companies, government agencies and leading academic institutions globally accelerate their research and drug development efforts. The company has a diverse portfolio of discovery and safety assessment services, both Good Laboratory Practice (GLP) and non-GLP. This helps support its clients from target identification through non-clinical development. Charles River also provides a line of products and services to support clients' manufacturing activities. Utilizing the company's broad portfolio of products and services, clients can create a more flexible drug development model, aiming cost reduction, productivity enhancement and increase in speed to market. Charles River currently has three reporting segments: Research Models and Services (RMS), Discovery and Safety Assessment (DSA) and Manufacturing Support.
Stock Name Country Market Cap PE Ratio
Elevance Health (ELV) United States $96.890B 12.02
Cencora (COR) United States $46.107B 17.62
DiDi Global (DIDIY) China $23.233B 0.00
ICON (ICLR) Ireland $18.679B 16.64
Revvity (RVTY) United States $15.535B 26.63
Avantor (AVTR) United States $15.498B 23.24
Natera (NTRA) United States $15.385B 0.00
Viatris (VTRS) United States $13.858B 4.22
BioMerieux (BMXMF) France $13.601B 0.00
Solventum (SOLV) United States $12.636B 0.00
CochLear (CHEOY) Australia $12.565B 0.00
Medpace Holdings (MEDP) United States $10.202B 28.74
Sonic Healthcare (SKHHY) Australia $8.273B 0.00
HealthEquity (HQY) United States $7.792B 42.29
Doximity (DOCS) United States $7.787B 49.34
Bausch + Lomb (BLCO) Canada $6.975B 32.47
Life Times (LTH) United States $4.762B 31.52
PACS (PACS) United States $4.502B 0.00
Sotera Health (SHC) United States $4.367B 23.36
Organon (OGN) United States $4.239B 4.28
Surgery Partners (SGRY) United States $3.778B 41.86
BrightSpring Health Services (BTSG) United States $3.070B 65.30
Ardent Health Partners (ARDT) United States $2.577B 0.00
Alignment Healthcare (ALHC) United States $2.546B 0.00
Concentras Parent (CON) United States $2.480B 0.00
Premier (PINC) United States $2.271B 11.34
GoodRx Holdings (GDRX) United States $2.254B 84.86
GeneDx Holdings (WGS) United States $2.057B 0.00
Ryman Healthcare (RYHTY) New Zealand $2.036B 0.00
Teladoc Health (TDOC) United States $1.575B 0.00
AMN Healthcare Services Inc (AMN) United States $1.507B 7.57
Progyny (PGNY) United States $1.425B 25.06
Establishment Labs Holdings (ESTA) $1.338B 0.00
Pediatrix Medical (MD) United States $1.319B 12.91
CareDx (CDNA) United States $1.228B 0.00
Agilon Health (AGL) United States $1.123B 0.00
Embecta (EMBC) United States $0.864B 5.76
InnovAge Holding (INNV) United States $0.822B 0.00
QDM (QDMI) Hong Kong, SAR China $0.790B 20.69
SBC Medicals (SBC) United States $0.722B 0.00
Auna S.A (AUNA) Luxembourg $0.488B 0.00
Sonida Senior Living (SNDA) United States $0.483B 0.00
Enhabit (EHAB) United States $0.382B 33.04
DocGo (DCGO) United States $0.355B 13.35
COMPASS Pathways (CMPS) United Kingdom $0.309B 0.00
Sera Prognostics (SERA) United States $0.255B 0.00
ModivCare (MODV) United States $0.232B 7.37
Beauty Health (SKIN) United States $0.211B 0.00
Biodesix (BDSX) United States $0.195B 0.00
LifeMD (LFMD) United States $0.192B 0.00
Ascend Wellness Holdings (AAWH) United States $0.178B 0.00
MultiPlan (MPLN) United States $0.136B 0.00
Nutex Health (NUTX) United States $0.127B 0.00
So-Young (SY) China $0.092B 22.35
Harvard Apparatus Regenerative Technology (HRGN) United States $0.059B 0.00
Singular Genomics Systems (OMIC) United States $0.057B 0.00
OncoCyte (OCX) United States $0.049B 0.00
NeueHealth (NEUE) United States $0.041B 1.63
Co-Diagnostics (CODX) United States $0.039B 0.00
IceCure Medical (ICCM) Israel $0.036B 0.00
NeuroOne Medical Technologies (NMTC) United States $0.027B 0.00
Pheton Holdings (PTHL) China $0.027B 0.00
Oncology Institute (TOI) United States $0.021B 0.00
SeaStar Medical Holding (ICU) United States $0.012B 0.00
XWELL (XWEL) United States $0.009B 0.00
Intelligent Bio Solutions (INBS) United States $0.007B 0.00
BioNexus Gene Lab (BGLC) $0.007B 0.00
KindlyMD (KDLY) United States $0.005B 0.00
ISpecimen (ISPC) United States $0.004B 0.00
NewGenIvf Group (NIVF) Thailand $0.003B 0.00
Aclarion (ACON) United States $0.002B 0.00
Cano Health (CANOQ) United States $0.001B 0.00